The current valuation score of Agenus Inc is 8.86, ranking 84 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 1.41, which is 22.60% below the recent high of 1.73 and 99677.57% above the recent low of -1408.82.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.